SPOTLIGHT -
Intravitreal pegcetacoplan for retinal tissue preservation in patients with GA
Garg reported the 30-month data showing that patients receiving pegcetacoplan experienced an increasing treatment effect compared with sham (ie, a decrease in GA lesion area over time).
Read More